司绒, 程明涵, 高建. 呼吸系统疾病潜在治疗靶点半乳糖凝集素-3的研究进展J. 药学学报, 2020,55(7): 1401-1409. doi: 10.16438/j.0513-4870.2020-0581
引用本文: 司绒, 程明涵, 高建. 呼吸系统疾病潜在治疗靶点半乳糖凝集素-3的研究进展J. 药学学报, 2020,55(7): 1401-1409. doi: 10.16438/j.0513-4870.2020-0581
SI Rong, CHENG Ming-han, GAO Jian. Recent research progress on galectin-3 as a potential therapeutic target in respiratory diseasesJ. Acta Pharmaceutica Sinica, 2020,55(7): 1401-1409. doi: 10.16438/j.0513-4870.2020-0581
Citation: SI Rong, CHENG Ming-han, GAO Jian. Recent research progress on galectin-3 as a potential therapeutic target in respiratory diseasesJ. Acta Pharmaceutica Sinica, 2020,55(7): 1401-1409. doi: 10.16438/j.0513-4870.2020-0581

呼吸系统疾病潜在治疗靶点半乳糖凝集素-3的研究进展

Recent research progress on galectin-3 as a potential therapeutic target in respiratory diseases

  • 摘要: 半乳糖凝集素-3属于半乳糖凝集素家族,是一种广泛分布于人体内的内源性β-半乳糖苷结合凝集素,在细胞的增殖、分化、凋亡、细胞黏附、免疫反应以及信号转导等多种功能中发挥重要作用。越来越多的证据表明,半乳糖凝集素-3参与了呼吸系统多种疾病的发生发展,涉及特发性肺纤维化、肺癌、肺动脉高压和支气管哮喘等疾病。本综述总结并分析了半乳糖凝集素-3在以上几种呼吸系统疾病中的研究进展,以阐明其在呼吸系统疾病中的作用及机制,希望为临床治疗提供新的思路。

     

    Abstract: Galectin-3 is an endogenous β-galactoside-binding lectin widely distributed in the human body, and it plays an important role in various functions such as cell proliferation, differentiation, apoptosis, cell adhesion, immune response and signal transduction. Accumulating evidence has shown that galectin-3 is involved in the occurrence and development of respiratory diseases, including idiopathic pulmonary fibrosis, lung cancer, pulmonary hypertension and bronchial asthma. This review summarizes and analyzes the research progress on galectin-3 in the above respiratory diseases in order to clarify its role and mechanism, and to provide new ideas for clinical treatment.

     

/

返回文章
返回